VISTAPH · VISTA PHARMACEUTICALS LTD. · Financials
Market Cap
384.70M INR
Shares
61.55M
Volume · Nov 13
19.25K
Avg daily vol (3M)
11.79K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
54M
-46.4%
FY2026
Net Income
-120.61M
-159.5%
FY2026
Operating Cash Flow
-44.01M
+37%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 38.81M | 54M | 100.75M |
| INR | 7.61M | 7.49M | 7.38M |
| INR | 12.44M | 11.01M | 9.64M |
| INR | -159.98M | -161.51M | -52.9M |
| INR | -42.42M | -40.9M | -6.41M |
| INR | -117.57M | -120.61M | -46.49M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.